Erbitux injection 500mg, manufactured by Merck Biopharma, contains Cetuximab (genetical recombination). With YJ code 4291415A2028 and standard 500mg 100mL 1 bottle, it is a monoclonal antibody used in the treatment of certain cancers, such as colorectal and head and neck cancers.
Erbitux injection 500mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →